Tectonic Therapeutic, Inc. SEC filings TECX

Tectonic Therapeutic, Inc. has 582 filings in SEC EDGAR's recent list, going back to Aug 3, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.

Tectonic Therapeutic, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Acquisition or sale of assets
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 29, 2026 —
4 Insider transaction Oct 28, 2026 Oct 26, 2026
4 Insider transaction Oct 2, 2026 Sep 25, 2026
4 Insider transaction Oct 2, 2026 Sep 25, 2026
4 Insider transaction Oct 2, 2026 Sep 25, 2026
4 Insider transaction Oct 2, 2026 Sep 25, 2026
4 Insider transaction Oct 2, 2026 Sep 25, 2026
144 Notice of proposed sale Sep 30, 2026 —
8-K Current report
Other events
Sep 29, 2026 Sep 29, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
144 Notice of proposed sale Aug 27, 2026 —
4 Insider transaction Aug 26, 2026 Aug 25, 2026
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
144 Notice of proposed sale Aug 12, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 23, 2026 Jun 20, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results, Other events
Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 9, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
3 Initial insider ownership Jun 10, 2026 Jun 8, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
4 Insider transaction May 6, 2026 May 4, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 8, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 23, 2026 Apr 23, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
3 Initial insider ownership Apr 3, 2026 Apr 1, 2026
4 Insider transaction Mar 9, 2026 Mar 6, 2026
4 Insider transaction Mar 9, 2026 Mar 6, 2026
S-8 POS Filing Mar 9, 2026 —
144 Notice of proposed sale Mar 6, 2026 —
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4 Insider transaction Mar 5, 2026 Mar 4, 2026
4/A Filing Mar 5, 2026 Feb 11, 2026
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
S-8 Employee stock plan registration Feb 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 27, 2026 —
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 24, 2026 Feb 23, 2026
4 Insider transaction Feb 12, 2026 Feb 11, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 10, 2026 Feb 4, 2026
4 Insider transaction Feb 10, 2026 Feb 4, 2026
4 Insider transaction Feb 10, 2026 Feb 4, 2026
4 Insider transaction Feb 10, 2026 Feb 4, 2026
4 Insider transaction Feb 10, 2026 Feb 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 29, 2026 —
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Dec 29, 2025 Dec 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 30, 2025 Oct 29, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
4 Insider transaction Sep 29, 2025 Sep 25, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
EFFECT Filing Jul 15, 2025 —
424B3 Prospectus Jul 15, 2025 —
CORRESP Letter to the SEC Jul 11, 2025 —
UPLOAD Letter from the SEC Jul 10, 2025 —
EFFECT Filing Jul 8, 2025 —
EFFECT Filing Jul 8, 2025 —
POS AM Filing Jul 7, 2025 —
POS AM Filing Jul 7, 2025 —
S-3 Shelf registration Jul 7, 2025 —
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
424B5 Prospectus supplement Jun 11, 2025 —
424B5 Prospectus supplement Jun 11, 2025 —
8-K Current report
Shareholder vote results
Jun 6, 2025 Jun 6, 2025
424B5 Prospectus supplement May 19, 2025 —
424B5 Prospectus supplement May 19, 2025 —
8-K Current report
Other events
May 19, 2025 May 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
424B3 Prospectus May 8, 2025 —
424B3 Prospectus May 8, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 6, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
4 Insider transaction Apr 9, 2025 Apr 7, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 7, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 7, 2025 —
4 Insider transaction Apr 7, 2025 Apr 7, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 7, 2025 —
EFFECT Filing Apr 3, 2025 —
EFFECT Filing Apr 2, 2025 —
CORRESP Letter to the SEC Mar 31, 2025 —
UPLOAD Letter from the SEC Mar 31, 2025 —
POS AM Filing Mar 27, 2025 —
S-1 Registration statement Mar 26, 2025 —
S-8 Employee stock plan registration Mar 20, 2025 —
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
D Filing Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
424B5 Prospectus supplement Feb 12, 2025 —
424B5 Prospectus supplement Feb 12, 2025 —
424B3 Prospectus Feb 12, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 10, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 7, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 7, 2025 —
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 3, 2025 Feb 3, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 30, 2025 Jan 30, 2025
4 Insider transaction Jan 29, 2025 Jan 28, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2025 —
4 Insider transaction Dec 11, 2024 Dec 9, 2024
4 Insider transaction Dec 6, 2024 Dec 4, 2024
4 Insider transaction Dec 5, 2024 Dec 3, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13D/A Amended ownership over 5% (active) Oct 28, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 24, 2024 —
4 Insider transaction Oct 24, 2024 Oct 22, 2024
SC 13D/A Amended ownership over 5% (active) Sep 26, 2024 —
4 Insider transaction Sep 26, 2024 Sep 24, 2024
8-K Current report
Regulation FD disclosure
Sep 19, 2024 Sep 19, 2024
S-8 POS Filing Aug 27, 2024 —
S-8 Employee stock plan registration Aug 21, 2024 —
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
424B3 Prospectus Aug 14, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
424B5 Prospectus supplement Jul 31, 2024 —
EFFECT Filing Jul 30, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jul 30, 2024 Jul 30, 2024
424B3 Prospectus Jul 30, 2024 —
CORRESP Letter to the SEC Jul 26, 2024 —
UPLOAD Letter from the SEC Jul 26, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 22, 2024 —
S-1 Registration statement Jul 19, 2024 —
SC 13G Ownership over 5% (passive) Jul 10, 2024 —
8-K Current report
Officer or director change
Jul 5, 2024 Jun 28, 2024
SC 13G Ownership over 5% (passive) Jul 1, 2024 —
SC 13D Ownership over 5% (active) Jun 27, 2024 —
SC 13D Ownership over 5% (active) Jun 26, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Jun 26, 2024 Jun 25, 2024
SC 13D Ownership over 5% (active) Jun 25, 2024 —
4 Insider transaction Jun 25, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024
3 Initial insider ownership Jun 24, 2024 Jun 20, 2024
4 Insider transaction Jun 24, 2024 Jun 20, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TECX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Watertown, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1681087
Former names
AvroBio, Inc. (until Jun 18, 2024); AVROBIO, Inc. (until Jun 18, 2024)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.